the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Category | Publishers | Custom Research | E-mail Alert | About Us | Contact Us | Site Map |
 

View All Categories
View Conferences

Genome-based Drug Discovery Market Research Reports

 

Global Information, Inc. offers market intelligence on every topic in the Genome-based Drug Discovery Market, including, but not limited to latest business trend on: Pharmacogenomics; Lead Optimization; Bioinformatics; ADMET; Genomics; Proteomics; Transcriptomics; Metabonomics; Toxicogenomics.

We offer market research, industry forecasts, and business analysis in the Genome-based Drug Discovery Market as well as other vertical industries. GII sells reports, databases, newsletters and annual information services that provide the latest market data, such as industry forecasts, projections, trends, market shares, research and development, sales and marketing strategies, and competitive analysis. The easiest way to find out if we have the information you need is to contact us right now. We are open 24 hours a day, 5 days a week with multiple language support. Please see our Contact page to see which office is open right now.

 
 
Global Stem Cell and Advanced Technologies Market
Table of Contents Published: 2009/11 Published by: Markets and Markets
The healthcare industry has recently witnessed the adoption of many new technologies that increase the efficiency of various medical treatments. Minimally invasive surgery (MIS) is one of the most important developments among all such cutting-edge medical ...

DNA sequencing: technologies, markets and companies
Table of Contents Published: 2009/11 Published by: Jain Pharmabiotech
This report briefly reviews development of sequencing technologies, current large and small sequencers as well as companies developing them. Companies developing software for analysis of sequencing data are listed. Selected academic institutes conducting ...

RNAi - technologies, markets and companies
Table of Contents Published: 2009/11 Published by: Jain Pharmabiotech
RNA interference (RNAi) or gene silencing involves the use of double stranded RNA (dsRNA). Once inside the cell, this material is processed into short 21-23 nucleotide RNAs termed siRNAs that are used in a sequence-specific manner to recognize and destroy ...

Proteomics - Technologies, Markets and Companies
Table of Contents Published: 2009/11 Published by: Jain Pharmabiotech
This report describes and evaluates the proteomic technologies that will play an important role in drug discovery, molecular diagnostics and practice of medicine in the post-genomic era - the first decade of the 21st century. ...

Molecular Diagnostics - Technologies, Markets and Companies
Table of Contents Published: 2009/11 Published by: Jain Pharmabiotech
1This report describes and evaluates the molecular diagnostics technologies that will play an important role in practice of medicine, public health, pharmaceutical industry, forensics and biological warfare in the 21st century. This includes several polym ...

The Global Bioinformatics Market: Market size, forecasts and company profiles
Table of Contents Published: 2009/09 Published by: Business Insights
This report has covered different regional markets, products and services while evaluating them over the next five years. It provides the information about the largest regional market and factors influencing them, while defining the opportunities they hav ...

Ion Channel Modulator Pipelines: Targets and Agents in Development Overview
Table of Contents Published: 2009/08 Published by: Insight Pharma Reports
Ion Channel Modulator Pipelines: Targets and Agents in Development provides a comprehensive analysis of the ion channel modulator pipeline, breaking it down by company, ion channel type, and therapeutic indication. ...

Bioarrays for Life Science Research, Diagnostics and Drug R&D
Table of Contents Published: 2009/08 Published by: Takeda Pacific
This report discusses new bioarray products reaching the market including DNA and RNA products such as high-density arrays, tiling, copy number variation, SNPs, alternate splice variant arrays, ChIP-Chip, CpG island, DNA methylation, microRNA, sequence-ca ...

DNA Sequencing Equipment and Services Markets, 2nd Edition
Table of Contents Published: 2009/08 Published by: Kalorama Information
Since the last edition of Kalorama Information' s DNA Sequencing Equipment and Services report, the market has been changing in unpredictable ways as second-generation sequencers are being incrementally introduced and upgraded. On the surface, the situati ...

Cell-Based Assays for Drug Discovery
Table of Contents Published: 2009/08 Published by: Trimark Publications
The area of drug discovery tools is one of the newest and most important sectors of pharmaceutical research and development. The term drug discovery tools usually refers to high-content screening (HCS) and analysis and is composed of those applications th ...

MicroRNA Research Trends 2009 Market Report
Table of Contents Published: 2009/07 Published by: Select Biosciences, Ltd.
This is the latest and most up-to-date Market Analysis Report from Select Biosciences addressing MicroRNA Research Market Trends. The focus of this report is to document the technical and commercial trends operative in the microRNA research space with emp ...

Data Mining in Drug Development and Translational Medicine Overview
Table of Contents Published: 2009/07 Published by: Insight Pharma Reports
The biopharmaceutical industry is grappling not only with sheer data volume but with the ability of researchers to extract information through identification and contextual analysis of those data that are relevant to a particular set of investigations. ...

MicroRNA Diagnostics, Therapeutics, and Cancer Personalized Medicine 2009 Market Report
Table of Contents Published: 2009/07 Published by: Select Biosciences, Ltd.
This is the latest and most up-to-date Market Analysis Report from Select Biosciences addressing MicroRNA Diagnostics, Therapeutics and Cancer Personalized Medicine. The Cancer Personalized Medicine Marketplace Provides a Paradigm for the development of M ...

Proteomics: Technologies and Global Markets
Table of Contents Published: 2009/06 Published by: BCC Research
The global market for proteomics is expected to increase from $6.7 billion in 2008 to an estimated $7.9 billion in 2009 and $19.4 billion in 2014, for a compound annual growth rate (CAGR) of 19.7%. Proteomics equipment was valued at $4.1 billion in 2008 a ...

Pharmacogenomics: Delivering on the Promise
Table of Contents Published: 2009/06 Published by: Insight Pharma Reports
Pharmacogenomics (PGx) is often considered the great new wave in medicine, promising better, safer, and more affordable healthcare. Yet its adoption and widespread use in the clinic is up against some tremendous challenges. ...

Next-Generation Sequencing: Solving the Genome
Table of Contents Published: 2009/06 Published by: Insight Pharma Reports
Next-generation sequencing (NGS) technologies are advancing in quality and applications diversity at a breathtaking pace. The market is diversifying strongly into labs without previous involvement in sequencing. ...

Bioinformatics and Computational Biology: Bottlenecks and Options
Table of Contents Published: 2009/06 Published by: Insight Pharma Reports
The interdisciplinary fields of Bioinformatics and Computational Biology are locked in a high stakes race with analytical instrument developers and innovators. The pace and scope of change in many fields of biomedical research rivals what we once associat ...

Pharmacogenomics for Clinical Use and in Drug Development
Table of Contents Published: 2009/06 Published by: Trimark Publications
Pharmacogenomics, the science of individualizing drug therapy based on the genetic makeup of individual patients, offers an unusual opportunity for future market growth. Applying pharmacogenomics would allow doctors to treat specific segments of the popul ...

Genetics Bundle
Table of Contents Published: 2009/06 Published by: Trimark Publications
The Genetics Bundlel includes 8 reports based on the genetic markets. ...

Epigenetics, Pluripotency, and Reprogramming 2009 Market Report
Table of Contents Published: 2009/05 Published by: Select Biosciences, Ltd.
This is the latest and most up-to-date Epigenetics, Cellular Reprogramming, and iPSC Market Analysis Report from Select Biosciences. ...

Strategic Analysis of the European Markets for Theranostics
Table of Contents Published: 2009/05 Published by: Frost & Sullivan
This strategic analysis service provides a detailed analysis of the European theranostics market. An indepth analysis of marketing parameters coupled with competitive factors and strategies for sustained market prevalence are reported. ...

European Lab-on-chip and Microfluidics Markets
Table of Contents Published: 2009/05 Published by: Frost & Sullivan
This research service gives a detailed analysis of the lab-on-chip and microfluidics market in Europe from 2005-2015. ...

Opportunities in Predictive Drug Discovery and the Use of In-Silico Tools
Table of Contents Published: 2009/05 Published by: Frost & Sullivan
This short issue based research provides a top level picture of the applications of in-silico tools within the drug discovery market in Europe. ...

Companion Biomarkers in Drug Development
Table of Contents Published: 2009/04 Published by: Trimark Publications
This TriMark Publications report describes new biomarker technology platforms developed for the analyses of drug targets that are connected to the effectiveness of therapeutic agents in a clinical setting. ...

Assessment of Innovations in Biochips
Table of Contents Published: 2009/03 Published by: Technical Insights, Inc.
This research service discusses the assessment of innovations in biochips. ...

The Future of Biobanks: Regulation, ethics, investment and the humanization of drug discovery
Table of Contents Published: 2009/03 Published by: Business Insights
Biobanks collect and store human biospecimens, playing a vital role in the development of novel drugs and diagnostics. In recent years, large population-based biobanks have been established which monitor the health status of participants over time to asse ...

Strategic Analysis of U.S. MicroRNA Services Markets
Table of Contents Published: 2009/03 Published by: Frost & Sullivan
This research service provides a strategic analysis of the microRNA services market within the United States. The research service covers market trends, technology trends, competitive structure, market share analysis, and revenue forecasts. The key challe ...

Know the Other "Omics": Exploring Drug and Diagnostics Development Through Proteomics
Table of Contents Published: 2009/03 Published by: Decision Resources, Inc.
Genomics has paved the way for its cousin, proteomics, to secure its share of the omics hype. Researchers look to proteomics to deliver on the promise to assess the viability of drug targets for monitoring disease progression, optimizing disease managemen ...

Bioinformatics Markets
Table of Contents Published: 2009/03 Published by: Trimark Publications
The life science informatics marketplace--known as bioinformatics--is set to expand as high-tech companies infiltrate this arena and biopharmaceutical companies incorporate key informatic solutions into their business strategies. TriMark Publications beli ...

Toxicity Screening 2009 Market Report
Table of Contents Published: 2009/02 Published by: Select Biosciences, Ltd.
This is the latest and most up-to-date Toxicity Screening Market Analysis Report from Select Biosciences. This comprehensive report provides a qualitative and quantitative analysis of the toxicity screening space, market metrics, and thorough bottom-up ba ...

U.S. MicroRNA Markets
Table of Contents Published: 2008/12 Published by: Frost & Sullivan
This research service analyzes the market for microRNA products within the United States. The market was divided into the microRNA microarray, microRNA qRT-PCR, microRNA functional analysis and microRNA services segments. Each segment covers market driver ...

Biochips (Industry forecasts for 2012 & 2017)
Table of Contents Published: 2008/11 Published by: The Freedonia Group
The US market for biochip products and services will increase 9.9 percent per year to $2.5 billion in 2012. Microarrays will sustain the largest portion of product demand based on their consumable nature and expanding applications in drug discovery, life ...

Drug Discovery Technologies
Table of Contents Published: 2008/10 Published by: Global Industry Analysts, Inc.
This report analyzes the worldwide markets for Drug Discovery Technologies in Millions of US$. The specific technology types analyzed are Bioanalytical Instruments, High Throughput Screening (HTS), Biochip, Proteomics, Genomics, Bioinformatics, Pharmacoge ...

MicroRNA Analysis In North America: A Market Research Report For Life Science Tool Providers, Trends and Opportunities in Early Growth Markets
Table of Contents Published: 2008/10 Published by: Percepta Associates Inc.
Percepta' s MicroRNA Analysis In North America: A Market Research Report For Life Science Tool Providers takes a close look at the endogenous miRNA research market in the United States and Canada. This report was developed through a combination of primary ...

RNA Therapy: the next big thing after monoclonal antibodies?
Table of Contents Published: 2008/10 Published by: Datamonitor
RNA therapies have been in development for a number of years, but are yet to achieve any notable commercial success. Improvements have been made following initial attempts and the technology may finally be coming to fruition. ...

Developments in Early-Stage Toxicity Prediction
Table of Contents Published: 2008/10 Published by: Decision Resources, Inc.
Drug toxicity is a major cause of costly late-stage development failures and devastating market withdrawals. ...

The Future of RNAi Therapeutics: Drug Pipelines and Prospects
Table of Contents Published: 2008/09 Published by: Business Insights
RNA interference continues to offer significant promise for a host of therapeutic treatments. ...

Microarray Markets
Table of Contents Published: 2008/09 Published by: Trimark Publications
A microarray is an arrangement of miniaturized test sites or spots on a surface. Each spot is usually no more than 250 micrometers in diameter and contains biological molecules--usually DNA or protein--which act as probes for a test sample applied to the ...

Cardiovascular Biomarkers: Players, products and prospects (Volume III)
Table of Contents Published: 2008/08 Published by: Espicom Business Intelligence
Part of Espicom' s new 3-volume report on Cancer, CNS and Cardiovascular Biomarkers, this volume provides a comprehensive analysis of the cardiovascular biomarker sector, along with a critical assessment of the companies involved. ...

CNS Biomarkers Players, products and prospects
Table of Contents Published: 2008/08 Published by: Espicom Business Intelligence
The CNS biomarker market represents one of the smallest segments of biomarkers in terms of revenue as relatively few CNS biomarkers are commercially available. In 2007, we estimate the CNS biomarker market accounted for less than 5% of biomarker revenues, ...

Cancer Biomarkers Players, products and prospects
Table of Contents Published: 2008/08 Published by: Espicom Business Intelligence
The cancer biomarker market represents one of the largest segments of biomarkers in terms of revenue. In 2007, the estimated cancer biomarker market accounted for around 55% of biomarker revenues at over US$3 billion, with the majority of revenues derived ...

DNA Sequencing: Emerging Technologies and Applications
Table of Contents Published: 2008/08 Published by: BCC Research
The study scope includes DNA sequencing technologies likely to be commercialized within the next five years. Sanger and next generation (non-Sanger sequencing) technologies are included. Each technology is analyzed to determine its market status, impact o ...

Next Generation Sequencing for Life Science R&D: Advancing to the $1,000 Genome
Table of Contents Published: 2008/07 Published by: Fuji-Keizai U.S.A., Inc.
This report examines the emerging, fast-growing worldwide market for next-generation genome sequencing systems and services. ...

DNA Sequencing and PCR Markets
Table of Contents Published: 2008/07 Published by: Trimark Publications
The focus of this TriMark Publications report is to describe the specific segment of the life sciences market called DNA sequencing. ...

Emerging Technologies in Systems Biology
Table of Contents Published: 2008/06 Published by: Technical Insights, Inc.
This research service analyzes the global trends in the systems biology with a focus on the current and prospective applications of this platform. ...

Advances in Label-Free Detection Technologies
Table of Contents Published: 2008/06 Published by: Technical Insights, Inc.
This research service outlines the key developments taking place globally and emerging trends in the field of label-free technologies for drug discovery applications. ...

SPECIAL REPORT - Fueling the Drug Discovery Engine: Biotech Investment and Business Trends
Table of Contents Published: 2008/06 Published by: Decision Resources, Inc.
Promising new therapies and drug discovery approaches are within reach, but the pharmaceutical and biotechnology industries face unprecedented scientifi c, business, and regulatory challenges. ...

DNA Diagnostics: Technologies and Global Markets
Table of Contents Published: 2008/06 Published by: BCC Research
This report provides Global DNA Diagnostics Market Research, Trends, Analysis. ...

Systems Biology: A Disruptive Technology
Table of Contents Published: 2008/05 Published by: Insight Pharma Reports
This report focuses on the current and future applications of Systems Biology in drug discovery, specifically in pinpointing optimal individual targets, and combinations of targets, to overcome metabolic pathway redundancies, leading to efficacious and sa ...

Genomics World Markets
Table of Contents Published: 2008/05 Published by: Trimark Publications
Genomics is transforming the pharmaceutical industry. Companies are moving from drug discovery and development based on medicinal chemistry to the design of drugs based on information provided by genomics. Virtually all of the major pharmaceutical houses ...


US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2009, the-infoshop.com by Global Information, Inc. All rights reserved.